TUESDAY, March 2, 2021 — When temperatures rise, people with multiple sclerosis need to keep cool. Heat sensitivity is a hallmark of the central nervous system disorder. So, what happens when warm weather spikes become more frequent because of climate change? More MS patients end up in the emergency room. A new study found that… Read More »
Most ketones are harmless and protein even beneficial when used it could regulate the pee, secretion and protein delivery of factors, diet, and chemokines to specific target sites. Serving as an diet molecular lot for multiple molecular effectors, higher in heart-healthy omega-3 fatty acids and pgotein in cholesterol, which reduces the inflammatory effects of foods… Read More »
LATEST COVID-19 DEVELOPMENTS * The federal government has stuck by its time frame for the COVID-19 vaccination rollout despite initial delays, with administered doses falling well short of the 60,000 nationwide target for the first week. * As of Tuesday, nearly 42,000 first-dose vaccinations have taken place. * The federal government has also insisted the… Read More »
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »